ArticleJournal of dental sciences2022
Residual antibacterial effects of a mixture of silver nanoparticles/calcium hydroxide and other root canal medicaments against
Article in Journal of dental sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 21 citations in OpenAlex.
- Applications of Nanomaterials in Restorative Dentistry and Endodontics: A Narrative Review.Materials (Basel, Switzerland) · 2026Review
- Article
- Antimicrobial effectiveness of intracanal medicaments againstFrontiers in oral health · 2026Review
- Comparison of the Antibacterial Effect of Nano-calcium Hydroxide and Nano-chlorhexidine Against Enterococcus Faecalis : Short title: Antibacterial Effects of Nano-Calcium Hydroxide and Nano-CHX.Galen medical journal · 2026Article
- Antimicrobial Efficacy of Intracanal Medicaments Incorporated With Nanoparticles in Primary Teeth: An In Vitro Study.TheScientificWorldJournal · 2025Article
- Novel approaches on root canal disinfection methods againstJournal of oral microbiology · 2025Review
- Comparative evaluation of removal of oil-based calcium hydroxide intracanal medicaments with two calcium chelators: AnJournal of conservative dentistry and endodontics · 2024Article
- Review
- Article
- [Antibacterial effect of low-temperature plasma onBeijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2023Article
- Silver Nanoparticles as an Intracanal Medicament: A Scoping Review.TheScientificWorldJournal · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/purpose: Intracanal medicaments with high residual inhibition effects are used to achieve successful endodontic treatment and prevent reinfection. This in vitro study aimed to assess antimicrobial residual effects of different intracanal medicaments against Materials and methods: Seventy human teeth were standardized to have 15 mm of length and were prepared by ProTaper rotary system. The teeth were randomly divided into six experimental (n = 10) and two control (n = 5) groups and subjected to drug therapy as follows; group CHX: 2% chlorhexidine gel, group CH: calcium hydroxide paste, group CH/CHX: mixture of calcium hydroxide and 2% CHX, group TAP: triple antibiotic paste, group DAP: double antibiotic paste, group CH/AgNPs: mixture of CH paste and silver nanoparticle suspension. After one week, the medicaments were removed from the root canals and Results: The difference between all experimental groups was statistically significant in this regard (P < 0.05) except for DAP and TAP groups, in which, no bacterial colony was noted after culture. After DAP and TAP, the lowest colony count was noted in CH/AgNPs, CH/CHX and CHX groups. The highest colony count was noted in CH group. Conclusion: Our results showed favorable residual antibacterial effects of TAP, DAP and CH/AgNP medicaments after one week of application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.